Vimarsana
Biggest News Aggregation in the World

Marc Van Dijk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marc Van Dijk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marc Van Dijk Today - Breaking & Trending Today

Science News | Study Finds How New Type of Cell Therapy Help ARDS Patients - Vimarsana News

Science News | Study Finds How New Type of Cell Therapy Help ARDS Patients

Get latest articles and stories on Science at LatestLY. A novel form of cell therapy may help patients who are critically ill with acute respiratory distress syndrome (ARDS) brought on by severe COVID-19, according to a study. Science News | Study Finds How New Type of Cell Therapy Help ARDS Patients.

New cancer drug could improve prognosis for Covid patients - Vimarsana News

New cancer drug could improve prognosis for Covid patients

A new cancer drug could improve the prognosis for patients whose lungs have been severely damaged by Covid.

Source: yahoo.com
New cell therapy shows promise for critically ill COVID-19 patients with ARDS - Vimarsana News

New cell therapy shows promise for critically ill COVID-19 patients with ARDS

Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe Covid-19.

New type of cell therapy shows promise for ARDS patients: Study - Vimarsana News

New type of cell therapy shows promise for ARDS patients: Study

The study shows that a new type of cell therapy can help in improve patients with acute respiratory distress syndrome (ARDS) caused by severe COVID-19. | Health

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications - Vimarsana News

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications

Treatment with agenT-797 Showed Improved Survival in Severe Respiratory DistressNEW YORK, Feb. 06, 2024 -- MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the...